Although this research focused on different cancer types and SWI/SNF components, it indicates potential links between SWI/SNF complex deficiencies and immunotherapy response, providing important references for understanding the role of other SWI/SNF complex components like BRG-1 in immunotherapy. Here, SMARCA1 is linked to cancer.